Preclinical development of TLR ligands as drugs for the treatment of chronic viral infections

Author： Zhang Xiaoyong   Kraft Anke   Broering Ruth   Schlaak Joerg F   Dittmer Ulf   Lu Mengji  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.7, Iss.7, 2012-07, pp. : 597-611

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Differentiation of CD8 T Cells in Response to Acute and Chronic Viral Infections: Implications for HIV Vaccine Development

By  

Current Drug Targets - Infectious Disorders, Vol. 5, Iss. 2, 2005-06 ,pp. : 121-129

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Viral Conjunctivitis with Antiviral Drugs

By Skevaki Chrysanthi L.  

Drugs, Vol. 71, Iss. 3, 2011-02 ,pp. : 331-347

Adis International

Access to resources Recommend Favorite

Preclinical development of cancer stem cell drugs

By Zhou Jiangbing   Zhang Ying  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 7, 2009-07 ,pp. : 741-752

Informa Healthcare

Access to resources Recommend Favorite

Viral Skin Infections: Diagnosis and Treatment Considerations

By Park K.C.   Han W.S.  

Drugs, Vol. 62, Iss. 3, 2002-01 ,pp. : 479-490

Adis International

Access to resources Recommend Favorite

Potential benefits of ibuprofen in the treatment of viral respiratory infections

By Winther Birgit  

Inflammopharmacology, Vol. 11, Iss. 4-6, 2003-12 ,pp. : 445-452

VSP

Access to resources Recommend Favorite